Volume 23, Number 10—October 2017
CME ACTIVITY - Synopsis
Fatal Rocky Mountain Spotted Fever along the United States–Mexico Border, 2013–2016
|Element||Case-patient 1||Case-patient 2||Case-patient 3||Case-patient 4|
|Known exposure in RMSF-epidemic area of Mexico||+||+||+|
|Evidence of receipt of medical care in Mexico||+||+|
|Prescribed nontetracycline antimicrobial drug
|Signs and symptoms at initial presentation|
|Severe end-stage manifestations|
|Disseminated intravascular coagulation||+|
*RMSF, Rocky Mountain spotted fever; +, present; blank cells, absent.
Page created: September 18, 2017
Page updated: September 18, 2017
Page reviewed: September 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.